Results 1 to 10 of about 53,170 (215)

Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease

open access: yesBrain Sciences, 2022
Parkinson’s disease (PD) is a chronic progressive neurodegenerative disease that is increasingly becoming a global threat to the health and life of the elderly worldwide.
Bin He   +2 more
exaly   +3 more sources

Mechanism-based inhibition of zinc-dependent histone deacetylases [PDF]

open access: yesRSC Chemical Biology
The hallmark of a mechanism-based inhibitor is a chemical transformation that occurs upon binding in an enzyme active site that typically yields a more potent inhibitory species. A mechanism-based enzyme inhibitor can be a closely-related analogue of the
David W. Christianson
doaj   +2 more sources

Histone deacetylases in cancer metabolic reprogramming [PDF]

open access: yesExperimental and Molecular Medicine
Cancer cells undergo extensive metabolic reprogramming to sustain rapid proliferation and adapt to heterogeneous tumour microenvironments. These metabolic alterations are tightly linked to epigenetic regulation, which reshapes gene expression and ...
Yu Hyun Jeon   +6 more
doaj   +2 more sources

Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma [PDF]

open access: yesOncology Reviews
Glioma is the most prevalent primary malignant tumor of the central nervous system. While traditional treatment modalities such as surgical resection, radiotherapy, and chemotherapy have made significant advancements in glioma treatment, the prognosis ...
Meng Ma   +6 more
doaj   +2 more sources

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer

open access: yesFrontiers in Oncology, 2022
Malignant ovarian tumors bear the highest mortality rate among all gynecological cancers. Both late tumor diagnosis and tolerance to available chemotherapy increase patient mortality.
Fengyi Guo, Hongjing Wang, Hongjing Wang
doaj   +1 more source

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke

open access: yesBiomedicines, 2021
Cerebral ischemia is the second leading cause of death in the world and multimodal stroke therapy is needed. The ischemic stroke generally reduces the gene expression due to suppression of acetylation of histones H3 and H4.
Svetlana Demyanenko   +2 more
doaj   +1 more source

Effect of Trichostatin A on Histone Deacetylases 1, 2 and 3, p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2 Gene Expression in Breast Cancer SK-BR-3 Cell Line

open access: yesAsian Pacific Journal of Cancer Biology, 2020
Objective: DNA methylation, the covalent addition of a methyl group to cytosine, and histone modification play an important role in the establishment and maintenance of the program of gene expression.
Masumeh Sanaei, Fraidoon Kavoosi
doaj   +1 more source

Histone deacetylases facilitate the accurate repair of broken forks

open access: yesMolecular & Cellular Oncology, 2020
We have recently uncovered that loss of the yeast histone deacetylases Rpd3 (Reduced Potassium Dependency 3) and Hda1 (Histone DeAcetylase 3) affects the cohesion between sister chromatids thus impairing repair of DNA damage at replication forks and ...
Belén Gómez-González   +2 more
doaj   +1 more source

Phylogenetic analysis, subcellular localization, and expression patterns of RPD3/HDA1 family histone deacetylases in plants

open access: yesBMC Plant Biology, 2009
Background Although histone deacetylases from model organisms have been previously identified, there is no clear basis for the classification of histone deacetylases under the RPD3/HDA1 superfamily, particularly on plants.
Yu Chun-Wei   +2 more
doaj   +1 more source

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis

open access: yesPharmaceuticals, 2022
Schistosomiasis is a major neglected parasitic disease that affects more than 240 million people worldwide and for which the control strategy consists of mass treatment with the only available drug, praziquantel.
Ehab Ghazy   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy